Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Deferred Taxes (2022 - 2025)

Bicycle Therapeutics' Deferred Taxes history spans 4 years, with the latest figure at $843000.0 for Q4 2025.

  • For Q4 2025, Deferred Taxes rose 181.53% year-over-year to $843000.0; the TTM value through Dec 2025 reached -$850000.0, up 83.74%, while the annual FY2025 figure was -$850000.0, 83.74% up from the prior year.
  • Deferred Taxes reached $843000.0 in Q4 2025 per BCYC's latest filing, up from -$46000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $7.3 million in Q3 2023 to a low of -$3.3 million in Q3 2024.
  • Average Deferred Taxes over 4 years is -$484125.0, with a median of -$817500.0 recorded in 2022.
  • Peak YoY movement for Deferred Taxes: surged 810.06% in 2023, then plummeted 266.67% in 2024.
  • A 4-year view of Deferred Taxes shows it stood at -$2.3 million in 2022, then skyrocketed by 87.93% to -$282000.0 in 2023, then tumbled by 266.67% to -$1.0 million in 2024, then skyrocketed by 181.53% to $843000.0 in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Deferred Taxes are $843000.0 (Q4 2025), -$46000.0 (Q3 2025), and -$331000.0 (Q2 2025).